Editorial: Community series in antimicrobial peptides: Molecular design, structure function relationship and biosynthesis optimization

COPYRIGHT © 2023 Yang, Aminov, Franco, de la Fuente-Nunez and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Editorial: Community series in antimicrobial peptides: Molecular design, structure function relationship and biosynthesis optimization

[1]  C. de la Fuente-Nunez,et al.  Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond , 2022, International journal of molecular sciences.

[2]  R. Aminov.  Editorial: Insights in antimicrobials, resistance, and chemotherapy: 2021 , 2022, Frontiers in Microbiology.

[3]  D. Teng,et al.  In Vitro Pharmacodynamics and Bactericidal Mechanism of Fungal Defensin-Derived Peptides NZX and P2 against Streptococcus agalactiae , 2022, Microorganisms.

[4]  O. Franco,et al.  Editorial: Antimicrobial Peptides: Molecular Design, Structure-Function Relationship, and Biosynthesis Optimization , 2022, Frontiers in Microbiology.

[5]  C. de la Fuente-Nunez,et al.  Deep generative models for peptide design , 2022, Digital discovery.

[6]  Guangshun Wang.  Unifying the classification of antimicrobial peptides in the antimicrobial peptide database. , 2022, Methods in enzymology.

[7]  Ting Li,et al.  Resistance response to Arenicin derivatives in Escherichia coli , 2021, Applied microbiology and biotechnology.

[8]  Marcelo C. R. Melo,et al.  Mining for encrypted peptide antibiotics in the human proteome , 2021, Nature Biomedical Engineering.

[9]  B. Yip,et al.  Boosting Synergistic Effects of Short Antimicrobial Peptides With Conventional Antibiotics Against Resistant Bacteria , 2021, Frontiers in Microbiology.

[10]  Marcelo C. R. Melo,et al.  Accelerating antibiotic discovery through artificial intelligence , 2021, Communications Biology.

[11]  G. Seibold,et al.  Angicin, a novel bacteriocin of Streptococcus anginosus , 2021, Scientific Reports.

[12]  D. Teng,et al.  A study on fungal defensin against multidrug-resistant Clostridium perfringens and its treatment on infected poultry , 2021, Applied Microbiology and Biotechnology.

[13]  D. Teng,et al.  Design and Pharmacodynamics of Recombinant Fungus Defensin NZL with Improved Activity against Staphylococcus hyicus In Vitro and In Vivo , 2021, International journal of molecular sciences.

[14]  D. Teng,et al.  The Pharmacodynamics Study of Insect Defensin DLP4 Against Toxigenic Staphylococcus hyicus ACCC 61734 in Vitro and Vivo , 2021, Frontiers in Cellular and Infection Microbiology.

[15]  Jacqueline R. M. A. Maasch,et al.  Molecular Dynamics for Antimicrobial Peptide Discovery , 2021, Infection and Immunity.

[16]  T. Lu,et al.  Synthetic Biology and Computer-Based Frameworks for Antimicrobial Peptide Discovery. , 2021, ACS nano.

[17]  Jianjun Cheng,et al.  Recent advances in design of antimicrobial peptides and polypeptides toward clinical translation. , 2021, Advanced drug delivery reviews.

[18]  D. Teng,et al.  An Enhanced Variant Designed From DLP4 Cationic Peptide Against Staphylococcus aureus CVCC 546 , 2020, Frontiers in Microbiology.

[19]  B. Lazzaro,et al.  Antimicrobial peptides: Application informed by evolution , 2020, Science.

[20]  O. Franco,et al.  Strategies for recombinant production of antimicrobial peptides with pharmacological potential , 2020, Expert review of clinical pharmacology.

[21]  Marlon H. Cardoso,et al.  Computer-Aided Design of Antimicrobial Peptides: Are We Generating Effective Drug Candidates? , 2020, Frontiers in Microbiology.

[22]  Abdul Sadat,et al.  Antimicrobial peptides from Bombyx mori: a splendid immune defense response in silkworms , 2019, RSC advances.

[23]  Karen G. N. Oshiro,et al.  Non-Lytic Antibacterial Peptides That Translocate Through Bacterial Membranes to Act on Intracellular Targets , 2019, International journal of molecular sciences.

[24]  Suzana M. Ribeiro,et al.  A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria. , 2019, Microbial pathogenesis.

[25]  D. Teng,et al.  Internalization, distribution, and activity of peptide H2 against the intracellular multidrug-resistant bovine mastitis-causing bacterium Staphylococcus aureus , 2019, Scientific Reports.

[26]  B. Levin,et al.  Antibiotic Killing of Diversely Generated Populations of Nonreplicating Bacteria , 2018, Antimicrobial Agents and Chemotherapy.

[27]  D. Teng,et al.  A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms , 2019, Applied Microbiology and Biotechnology.

[28]  D. Wibowo,et al.  Recent achievements and perspectives for large-scale recombinant production of antimicrobial peptides , 2018, Applied Microbiology and Biotechnology.

[29]  A. Travis,et al.  Antimicrobial drug discovery: lessons of history and future strategies , 2018, Expert opinion on drug discovery.

[30]  T. Lu,et al.  In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design , 2018, Nature Communications.

[31]  D. Teng,et al.  Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo , 2018, Scientific Reports.

[32]  A. J. Mason,et al.  Cationic antimicrobial peptides do not change recombination frequency in Escherichia coli , 2018, Biology Letters.

[33]  D. Teng,et al.  A review of the design and modification of lactoferricins and their derivatives , 2018, BioMetals.

[34]  T. Lu,et al.  Yeast-Based Synthetic Biology Platform for Antimicrobial Peptide Production. , 2018, ACS synthetic biology.

[35]  C. Zhai,et al.  The heterologous expression strategies of antimicrobial peptides in microbial systems. , 2017, Protein expression and purification.

[36]  Saloni R. Jain,et al.  Understanding and Sensitizing Density-Dependent Persistence to Quinolone Antibiotics. , 2017, Molecular cell.

[37]  D. Teng,et al.  Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus , 2017, Scientific Reports.

[38]  D. Fremont,et al.  Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist , 2017, Nature.

[39]  Guozhi Yu,et al.  Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics , 2017, bioRxiv.

[40]  D. Teng,et al.  Research advances on plectasin and its derivatives as new potential antimicrobial candidates , 2017 .

[41]  D. Teng,et al.  Research and development on lactoferrin and its derivatives in China from 2011-2015. , 2017, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[42]  Xia Li,et al.  APD3: the antimicrobial peptide database as a tool for research and education , 2015, Nucleic Acids Res..

[43]  D. Teng,et al.  Multiple copies of the target gene enhances plectasin secretion in Pichia pastoris X-33 , 2015 .

[44]  Xintao Cao,et al.  Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33 , 2015, BMC Microbiology.

[45]  Xintao Cao,et al.  Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33 , 2015, BMC Microbiology.

[46]  J. Rolff,et al.  Antimicrobials, Stress and Mutagenesis , 2014, PLoS pathogens.

[47]  D. Teng,et al.  High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus , 2013, Applied Microbiology and Biotechnology.

[48]  D. Teng,et al.  Expression of plectasin in Pichia pastoris and its characterization as a new antimicrobial peptide against Staphyloccocus and Streptococcus. , 2011, Protein expression and purification.

[49]  T. Ganz.  Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.

[50]  Michael A. Savageau,et al.  Escherichia coli Habitats, Cell Types, and Molecular Mechanisms of Gene Control , 1983, The American Naturalist.